- Home
- DEC vs PRAX Comparison
DEC vs PRAX Comparison
Compare DEC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEC
- PRAX
- Stock Information
- Founded
- DEC 2001
- PRAX 2015
- Country
- DEC United States
- PRAX United States
- Employees
- DEC N/A
- PRAX N/A
- Industry
- DEC
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- DEC
- PRAX Health Care
- Exchange
- DEC Nasdaq
- PRAX Nasdaq
- Market Cap
- DEC 884.9M
- PRAX 950.8M
- IPO Year
- DEC N/A
- PRAX 2020
- Fundamental
- Price
- DEC $15.04
- PRAX $46.85
- Analyst Decision
- DEC Strong Buy
- PRAX Strong Buy
- Analyst Count
- DEC 4
- PRAX 9
- Target Price
- DEC $21.50
- PRAX $94.44
- AVG Volume (30 Days)
- DEC 309.3K
- PRAX 388.4K
- Earning Date
- DEC 01-01-0001
- PRAX 08-04-2025
- Dividend Yield
- DEC 5.39%
- PRAX N/A
- EPS Growth
- DEC N/A
- PRAX N/A
- EPS
- DEC N/A
- PRAX N/A
- Revenue
- DEC $1,148,432,000.00
- PRAX $7,765,000.00
- Revenue This Year
- DEC $124.30
- PRAX N/A
- Revenue Next Year
- DEC $2.00
- PRAX $25.00
- P/E Ratio
- DEC N/A
- PRAX N/A
- Revenue Growth
- DEC 64.19
- PRAX 338.45
- 52 Week Low
- DEC $10.08
- PRAX $26.70
- 52 Week High
- DEC $17.70
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- DEC 42.67
- PRAX 47.63
- Support Level
- DEC $14.96
- PRAX $44.13
- Resistance Level
- DEC $16.61
- PRAX $47.06
- Average True Range (ATR)
- DEC 0.40
- PRAX 2.18
- MACD
- DEC -0.11
- PRAX 0.05
- Stochastic Oscillator
- DEC 4.22
- PRAX 54.73
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.